Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Alder Biopharmaceuticals Inc

+ Add to Watchlist

3A9:GR

23.964 EUR 0.248 1.02%

As of 10:04:40 ET on 03/27/2015.

Snapshot for Alder Biopharmaceuticals Inc (3A9)

Open: 24.049 Day's Range: 23.964 - 25.202 Volume: 0
Previous Close: 24.212 52wk Range: 7.169 - 27.449 1-Yr Rtn: -

Stock Chart for 3A9

No chart data available.
  • 3A9:GR 25.202
  • 1D
  • 1M
  • 1Y
24.212
Interactive 3A9 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 3A9

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2015) -1.6570
Est. PEG Ratio -
Market Cap (M EUR) 908.81
Shares Outstanding (M) 37.92
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/15/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 3A9

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 3A9

Alder Biopharmaceuticals, Inc. provides pharmaceutical products and services. The Company offers identifies, develops, and manufactures antibody therapeutics to alleviate human suffering in cancer, pain, cardiovascular, and autoimmune and inflammatory disease areas. Alder Biopharmaceuticals operates in the United States.

Randall C SchatzmanPresident/CEO/Co-FounderMark J LittonChief Bus Ofcr/Treasurer/Secy
John A LathamChief Scientific Ofcr/Co-FounderLarry K BenedictSenior VP:Finance
More Company Profile & Key Executives for 3A9

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil